Evolution of Practice During the Interventional Management of Stroke III Trial and Implications for Ongoing Trials [Clinical Sciences]

Conclusions—
Endovascular technology and diagnostic approaches to acute stroke patients changed substantially during the IMS III Trial. Efforts to decrease the time to delivery of endovascular therapy were successful.

Source: Stroke - November 24, 2014 Category: Neurology Authors: Broderick, J. P., Palesch, Y. Y., Demchuk, A. M., Yeatts, S. D., Khatri, P., Hill, M. D., Jauch, E. C., Jovin, T. G., Yan, B., von Kummer, R., Molina, C. A., Goyal, M., Mazighi, M., Schonewille, W. J., Engelter, S. T., Anderson, C., Spilker, J., Carrozzel Tags: Acute Cerebral Infarction, Emergency treatment of Stroke, Thrombolysis, Other Stroke Treatment - Surgical Clinical Sciences Source Type: research